Ignite Creation Date:
2025-12-24 @ 4:39 PM
Ignite Modification Date:
2026-04-13 @ 9:28 PM
Study NCT ID:
NCT01234766
Status:
COMPLETED
Last Update Posted:
2021-05-18
First Post:
2010-10-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bendamustine and Rituximab Followed by 90-yttrium (Y) Ibritumomab Tiuxetan for Untreated Follicular Lymphoma
Sponsor:
Dartmouth-Hitchcock Medical Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
D1015
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None